[Mouse models of hematological diseases using genome editing technology]

Area of Science:

• Developmental Engineering
• Hematology
• Genomics

Background:

• Conventional embryonic stem cell-based gene targeting in mice is time-consuming, often requiring up to two years.
• Gene targeting is crucial for understanding gene function and modeling human diseases.

Approach:

• This review highlights the advantages of modern gene-editing technologies for gene targeting in mice.
• Focuses on the efficiency and reduced labor compared to traditional methods.
• Discusses the application of gene editing in hematological research.

Key Points:

• Gene-editing tools enable rapid gene targeting in mice within 2-3 months.
• This technology bypasses several complex and labor-intensive steps of conventional methods.
• The review emphasizes the benefits for hematology research and the creation of mouse models for human diseases.

Conclusions:

• Gene-editing technology offers a significantly faster and more efficient approach to gene targeting in mice.
• It facilitates the study of myeloid malignancies and the development of accurate mouse models for human diseases.
• The ongoing advancements in genome editing promise to further revolutionize developmental engineering and hematological research.